Physician profile
Jacob Eisdorfer
NPI 1487706255
$1,803.64
in general payments reported to CMS, 2019-2025
18 companies · $50.71 in 2025
The $50.71 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $43.76 · 2021: $149 · 2022: $66.42 · 2023: $1,097 · 2024: $98.07 · 2025: $50.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,035 · Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,035.31 |
| Food and Beverage | $210.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,074.81 | 2021-2023 | Da Vinci Surgical System |
| Biom'Up Sa | $196.12 | 2019 | |
| Coloplast Corp | $104.25 | 2019-2021 | |
| Solventum Corporation | $72.86 | 2024-2025 | Prevena, Abthera Advance, V.A.C. Veraflo Cleanse Choice |
| Abbvie INC. | $41.37 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.18 | 2019 | |
| Ethicon US, LLC | $38.02 | 2021 | |
| Davol INC. | $37.45 | 2024 | Phasix Mesh |
| Advanced Oxygen Therapy INC. | $32.50 | 2022 | |
| Medline Industries Lp | $26.25 | 2022 | |
| Shire North American Group INC | $24.91 | 2019 | |
| Pfizer INC. | $22.92 | 2023 | |
| Novo Nordisk INC | $21.07 | 2020 | |
| Xeris Pharmaceuticals, INC. | $19.08 | 2023 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $17.03 | 2025 | Gattex |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $16.69 | 2021 | |
| Merck Sharp & Dohme LLC | $12.46 | 2021 | |
| Ambu INC. | $7.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Eisdorfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.